๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 51 Guanzhou 5 Foshan 3 Shaoguan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou51 Guanzhou5 Foshan3 Shaoguan1
All 4 locations
Target enrolment
to

Trials with a site in Guangzhou

51 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
NCT06902012Relapsed/Refractory Diffuse Large B-cell Lymphoma
Zhujiang Hospital
Phase 1/2
15
Guangzhou
2027-02
Not yet open
Plasma Neprilysin for Predicting Sepsis Within 48 Hours in ICU Patients With Infection or Suspected Infection
NCT07796386Sepsis, Infection
Zhujiang Hospital
Observational
488
Guangzhou
2026-08-01
Not yet open
Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia
NCT07696481Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Acute Myeloid Leukemia (AML)
Zhujiang Hospital
Phase EARLY_PHASE1
18
Guangzhou
2026-08-01
Recruiting
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
NCT07380113Pruritus Chronic, Kidney Diseases, Chronic, Renal Insufficiency, Chronic, Uremia; Chronic
Zhujiang Hospital
Phase 4
50
Guangzhou
2026-06-22
Recruiting
Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)
NCT07469072Continuous Renal Replacement Therapy (CRRT)
Zhujiang Hospital
Phase 2
92
Guangzhou
2026-04-07
Not yet open
An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease
NCT07455149Metabolic Dysfunction-associated Fatty Liver Disease
Zhujiang Hospital
Observational
200
Guangzhou
2026-04-01
Not yet open
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07457099Locally Advanced Oral Squamous Cell Carcinoma, Locally Advanced Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital
Observational
85
Guangzhou
2026-04-01
Recruiting
Effectiveness of tTIs for Improving Consciousness in Patients With DoC
NCT07539740Disorders of Consciousness, Vegetative State, Minimally Conscious State
Zhujiang Hospital
Not applicable
136
Guangzhou
2026-03-08
Recruiting
Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07686575HNSCC, OSCC, OPSCC, Ivonescimab
Zhujiang Hospital
Observational
20
Guangzhou
2026-01-26
Recruiting
Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
NCT07534033NSCLC Diagnosed by Histology or Cytology, A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resection, Overall Lung Function is Adequate for the Planned Lung Resection, AJCC is Classified as IB-IIIC
Zhujiang Hospital
Phase 2
46
Guangzhou
2025-12-06
Recruiting
Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)
NCT07362095Acute Leukemia
Zhujiang Hospital
Phase 1/2
46
Guangzhou
2025-10-01
Recruiting
Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy
NCT07111455Locally Advanced Oral Squamous Cell Carcinoma
Zhujiang Hospital
Observational
32
Guangzhou
2025-07-22
Recruiting
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
NCT07072494Acute Lymphoblastic Leukemia
Zhujiang Hospital
Phase 1/2
30
Guangzhou
2025-07-19
Not yet open
Effect of Vegan Diet on Microbiome and Metabolism
NCT07003230Vegan Diet
Zhujiang Hospital
Not applicable
20
Guangzhou
2025-05-30
Recruiting
Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study
NCT06861114Hepatocellular Carcinoma (HCC)
Zhujiang Hospital
Observational
38
Guangzhou
2025-02-20
Recruiting
A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke
NCT06712004Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction, Brain Diseases
Zhujiang Hospital
Phase 2
40
Guangzhou
2025-02-10
Recruiting
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
NCT06726460Electrolyte Disorder, Arrhythmia, Stroke
Zhujiang Hospital
Observational
200
Guangzhou
2024-12-17
Active, closed
Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions
NCT06716047Microecological Therapy, Probiotic Intervention
Zhujiang Hospital
Phase EARLY_PHASE1
30
Guangzhou
2024-12-05
Not yet open
The Correlation Characteristics Between Mental Health and Gut Microbiota of College Students in Qingyuan Vocational Education City
NCT06595095Depression, Anxiety
Zhujiang Hospital
Observational
600
Guangzhou
2024-10-01
Recruiting
Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer
NCT05067101Bladder Cancer
Zhujiang Hospital
Not applicable
126
Guangzhou
2024-09-10
Recruiting
The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
NCT07330362Chronic Glomerulonephritis, Chronic Kidney Disease
Zhujiang Hospital
Observational
2,900
Guangzhou
2024-07-01
Recruiting
RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
NCT06341400Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Zhujiang Hospital
Phase 1/2
55
Guangzhou
2024-06-19
Not yet open
Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma
NCT06449846Hepatocellular Carcinoma Resectable, Surgery, Recurrence
Zhujiang Hospital
Observational
152
Foshan, Guangzhou, Guanzhou
2024-06-01
Recruiting
Hemodynamic Study of In-Stent Stenosis(I) After Flow Diverter(F) Based on 3D-DSA(D) Combined With TCCD(T)
NCT06448949Hemodynamics;In-stent Stenosis;Transcranial Doppler;Intracranial Aneurysm;Flow Diverter; Prospective Cohort Study
Zhujiang Hospital
Observational
200
Guangzhou
2024-06-01
Recruiting
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
NCT06449833Type2 Diabetes Mellitus, Nonalcoholic Fatty Liver Disease
Zhujiang Hospital
Phase 4
100
Guangzhou
2024-06
Recruiting
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Patients With Disorders of Consciousness
NCT07284732Disorders of Consciousness
Zhujiang Hospital
Not applicable
20
Guangzhou
2024-05-01
Not yet open
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS
NCT06317896Hepatocellular Carcinoma, Circulating Tumor Cell, Recurrence, Surgery
Zhujiang Hospital
Observational
82
Foshan, Guangzhou
2024-04-01
Recruiting
The Correlation of Intracranial Artery Calcification and Outcomes of Mechanical Thrombectomy
NCT06418698Stroke, Acute, Ischemic Stroke, Vascular Diseases, Central Nervous System Diseases
Zhujiang Hospital
Observational
434
Guangzhou
2024-03-28
Recruiting
A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NCT06215495Radiation Toxicity, MRI Simulated Positioning, High Grade Glioma, Progression-free Survival
Zhujiang Hospital
Not applicable
88
Guangzhou
2024-02-18
By invitation
The Construction and Effect Verification of a Deep Learning-based Automated Semantic Segmentation Model for Medical Imaging
NCT06864702Artificial Intelligence (AI), Deep Learning, Laparoscopic Surgery
Zhujiang Hospital
Not applicable
220
Guangzhou
2023-12-20
Recruiting
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA
NCT06157060Hepatocellular Carcinoma Resectable
Zhujiang Hospital
Observational
255
Foshan, Guangzhou, Shaoguan
2023-11-20
By invitation
Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer
NCT07112209Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer
Zhujiang Hospital
Not applicable
20
Guangzhou
2023-11-06
Recruiting
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
NCT06082284Multiple Myeloma, M Protein
Zhujiang Hospital
Observational
10,000
Guangzhou
2023-10-01
Recruiting
Detection of Sepsis Occurrence by Using Blood Fluorescence
NCT06745115Sepsis
Zhujiang Hospital
Observational
90
Guangzhou
2023-09-09
Recruiting
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
NCT07133958Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC)
Zhujiang Hospital
Observational
35
Guangzhou
2023-07-11
Recruiting
A Study on the Correlation Between Endometriosis and Intra-tissue Microbiota
NCT06266897Endometriosis
Zhujiang Hospital
Observational
500
Guangzhou
2023-06-18
Recruiting
Risk Assessment and Mechanism Analysis of Intracranial Multiple Aneurysm Instability Based on High-resolution Magnetic Resonance, Imaging Histology and Hemodynamics
NCT06539767Arterial Aneurysm Wall Enhancement on HRMRI
Zhujiang Hospital
Observational
1,000
Guangzhou
2023-01-01
Recruiting
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
NCT05686447Monoclonal Gammopathies, Multiple Myeloma, M-protein
Zhujiang Hospital
Observational
200
Guangzhou
2023-01-01
Recruiting
A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
NCT05445544Preeclampsia, Microbiome
Zhujiang Hospital
Observational
10,000
Guangzhou
2022-10-19
Recruiting
Pipeline Embolization for Intracranial Aneurysms
NCT06446778Efficacy, Self, Hemodynamic Instability, Stenosis, Aneurysm, Intracranial
Zhujiang Hospital
Observational
1,000
Guangzhou
2022-09-01
Recruiting
A Study on the Correlation Between Cotinine Levels and Aneurysm Wall Enhancement on HRMRI.
NCT06447714Cotinine Levels, Arterial Aneurysm Wall Enhancement on HRMRI
Zhujiang Hospital
Observational
450
Guangzhou
2022-09-01
Recruiting
The Supraspinal Control of Lower Urinary Tract Function in Patients with Orthotopic Sigmoid Neobladder.
NCT05558111Orthotopic Neobladder
Zhujiang Hospital
Observational
40
Guangzhou
2022-06-01
Recruiting
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
NCT06097065Prediabetes, Diabetes Mellitus, Gestational Diabetes Mellitus, Proteomics
Zhujiang Hospital
Observational
2,860
Guangzhou
2022-05-20
Recruiting
Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam
NCT05160987Sedation and Analgesia
Zhujiang Hospital
Not applicable
440
Guangzhou
2022-03-29
Recruiting
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
NCT05462366Healthy, Breast-milk Collection, Feces
Zhujiang Hospital
Observational
100
Guangzhou
2021-06-22
Recruiting
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
NCT04861584Urinary Bladder Cancer
Zhujiang Hospital
Phase 2
41
Guangzhou
2021-06-03
Recruiting
Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China
NCT06456814Intracranial Aneurysm, Subarachnoid Hemorrhage, Aneurysmal, Cerebral Aneurysm, Brain Aneurysm
Zhujiang Hospital
Observational
30,000
Guangzhou
2010-01-01
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Guangzhou that also match the filters currently applied.

How many clinical trials are recruiting in Guangzhou?

38 of the 51 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 10 have not yet opened recruitment, 1 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Guangzhou), 51 studies
PhaseStudiesRecruitingShare
Observational292256.9%
Not applicable8515.7%
Phase 1/2447.8%
Phase 2447.8%
Phase 4223.9%
Phase EARLY_PHASE1203.9%
Phase 1102%
Phase 2/3112%

Most active sponsors

Lead sponsors with the most studies (Guangzhou)
Lead sponsorStudiesRecruiting
Zhujiang Hospital5138
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.